Page 178 - FBL AR 2019-20
P. 178

Fermenta Biotech Limited
           Annual Report 2019-20



          Consolidated Balance sheet as at March 31, 2020
                                                                                                      ( H in Lakhs )
                                                                             Notes   March 31, 2020  March 31, 2019*
          ASSETS
            Non-current assets
            a) Property, plant and equipment                                  3           10,400.35      9,730.32
            b) Capital work-in-progress                                                    6,707.51      2,072.16
            c) Right-of-use assets                                            4            1,428.46          -
            d) Investment property                                            5A           7,126.17      7,382.81
            e) Goodwill                                                       5B            412.79        412.79
            f) Other intangible assets                                        6             647.56        230.20
            g) Intangible assets under development                                          369.38        85.99
            h) Investments in an associate                                    7                -             -
            i)  Financial assets
              i)  Investments                                                 8              25.60        58.19
              ii) Share application money                                     9                -          597.00
              iii)  Loans                                                     10             25.00        25.32
              iv) Others financial assets                                     11            405.68        462.75
            j)  Deferred tax assets (net)                                    59C           3,810.51      1,931.70
            k) Non-current tax assets (net)                                   12            908.25        333.18
            l)  Other non-current assets                                      13            698.88       2,241.39
            Total non-current assets                                                      32,966.14     25,563.80
            Current assets
            a) Inventories                                                    14          12,858.19      8,766.53
            b) Financial assets
              i)  Investments                                                 15               -          114.79
              ii) Trade receivables                                           16           6,977.42      6,554.40
              iii) Cash and cash equivalents                                  17            751.45       4,076.50
              iv) Bank balances other than (iii) above                        18           2,559.54      5,036.92
              v) Loans                                                        19           2,130.00      1,180.26
              vi) Other financial assets                                      20            637.27        258.22
            c) Other current assets                                           21           2,487.44      3,573.29
            Total current assets                                                          28,401.31     29,560.91
            TOTAL ASSETS                                                                  61,367.45     55,124.71
          EQUITY AND LIABILITIES
          Equity
            a) Equity share capital                                           22           1,442.37       458.64
            b) Equity shares pending issuance                                                  -          22.15
            c) Other equity                                                   23          29,501.17     24,573.99
          Equity attributable to owners of the Company                                    30,943.54     25,054.78
          Non-controlling interests                                                          1.24          1.82
          Total equity                                                                    30,944.78     25,056.60
          Liabilities
            Non-current liabilities
            a)  Financial liabilities
              i)  Borrowings                                                  24          10,178.67     13,520.93
              ii) Lease liabilities                                           43            264.07           -
              iii) Other financial liabilities                                25             59.44        185.18
            b) Provisions                                                     26            405.83        630.94
            c) Other non-current liabilities                                  27             54.93        133.41
            Total non-current liabilities                                                 10,962.94     14,470.46
            Current liabilities
            a) Financial liabilities
              i)  Borrowings                                                  28          10,433.30      6,021.25
              ii) Lease liabilities                                           43            104.85           -
              iii) Trade payables
                A) Total outstanding dues of micro and small enterprises and;  65            98.01        97.89
                B)  Total outstanding dues of creditors other than micro and small enterprises   5,535.46    4,174.08
              iv) Other financial liabilities                                 29           2,973.76      4,251.90
            b) Other current liabilities                                      30            233.62        489.79
            c) Provisions                                                     31             48.71        50.23
            d) Current tax liabilities (net)                                  32             32.02        512.51
            Total current liabilities                                                     19,459.73     15,597.65
             TOTAL EQUITY AND LIABILITIES                                                 61,367.45     55,124.71
          *(Refer note 1.2)
          See accompanying notes 1 to 69 to the Consolidated financial statements
          In terms of our report attached
          For DELOITTE HASKINS & SELLS LLP    For and on behalf of the Board of Directors of
          Chartered Accountants               Fermenta Biotech Limited (Formerly known as DIL Limited)

          Rajesh K. Hiranandani               Krishna Datla            Satish Varma     Prashant Nagre
          Partner                             Managing Director        Executive Director   Chief Executive Officer

                                              Sumesh Gandhi            Srikant N. Sharma
                                              Chief Financial Officer   Company Secretary
          Mumbai, August 28, 2020             Thane, August 28, 2020





          176
   173   174   175   176   177   178   179   180   181   182   183